Rising Omicron cases can impact growth by 0.3% in March quarter: Report

The downside risks at the current juncture emanate from more states imposing restrictions, the restrictions extending beyond January 2022 and also a slowdown in global recovery: Economists

covid testing
A man gets a nose swab for a Covid-19 RT PCR test at a vaccination center in New Delhi, India, on Monday, Jan. 3, 2022. Photo: T. Narayan/Bloomberg
Press Trust of India Mumbai
2 min read Last Updated : Jan 04 2022 | 4:15 PM IST

Growth might be impacted by up to 0.30 per cent in the March quarter as normal economic activities come under pressure due to restrictions being imposed by more states to curb rising Omicron cases, economists at the country's largest private sector lender HDFC Bank said on Tuesday.

The economists said they were earlier estimating Q4 growth to come at 6.1 per cent, which can get impacted by 0.2-0.3 per cent because of the Omicron threat.

"With states imposing COVID-related restrictions (night curfew on movement of people, restaurants allowed at 50 per cent capacity, offices to operate at 50 per cent capacity in various states), economic activity is likely to get impacted in Q4FY22," they said.

The downside risks at the current juncture emanate from more states imposing restrictions, the restrictions extending beyond January 2022 and also a slowdown in global recovery which will weigh on the exports, they said in a note.

Experience from previous waves during the COVID pandemic suggests that restrictions are imposed on mobility as COVID cases rise, which in turn has an impact on economic activity, they said.

It said the Omicron cases are spreading at a faster pace in India and about 60 per cent of the overall infections are reported to be that of the new variant.

The overall Omicron tally stood at 1,700 as of Monday but the actual number could be higher as India has very few testing facilities to check genome sequencing, it said, adding that some media reports peg the total Omicron cases at 18,000 in the country.

The note also said that despite the threat of the Omicron, the rupee will stay range bound between Rs 74-76 to the greenback, and added that the RBI will intervene if the need arises.

Rate hike expectations will moderate as the growth gets impacted and the reverse repo hike expected in February is also uncertain now, it said, adding that the central bank will continue with its focus on liquidity normalisation and capping yields.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 04 2022 | 4:15 PM IST

Next Story